Vorträge und Abstracts (Auswahl)
Feiner LK, Thomas A, Rubie C, Glanemann M. A new regulatory mechanism associated with aging. 23. Chirurgische Forschungstage, 12 – 14.09.2019, Aachen.
Feiner LK, Thomas A, Rubie C, Glanemann M. 23. Regulation of Diabetes Type 2 and Obesity by the mTOR pathway. Chirurgische Forschungstage, 12 – 14.09.2019, Aachen.
Feiner LK, Thomas A, Rubie C, Glanemann M. Age-associated changes in the expression profile of aging related plasmaproteins. 23. Chirurgische Forschungstage, 12 – 14.09.2019, Aachen.
Rubie C, Feiner LK and Glanemann M. Symposium of the Heart Centre, University Hospital Halle (Saale) „Epigenetics: Playing with the Game of Life“13.09. – 15.09.2019 Halle. A new regulatory mechanism in ageing.
Rubie C, Feiner LK and Glanemann M. Symposium of the Heart Centre, University Hospital Halle (Saale) „Epigenetics: Playing with the Game of Life “Halle, 13. – 15.09.2019. Diabetes mellitus type 2 and obesity are potentially regulated by the mTOR pathway under the control of miR-496.
Feiner LK, Rubie C, Glanemann M. Ein neuer regulatorischer Mechanismus, der an Alterungsprozessen beteiligt ist. 136. Kongress Deutsche Gesellschaft für Chirurgie, 26 – 29.03.2019, ICM München.
Feiner LK, Thomas A, Rubie C, Zimmer J, Glanemann M. Diabetes mellitus Typ 2 und Fettleibigkeit werden mutmaßlich durch den mTOR Signalweg unter der Kontrolle der miRNA-496 reguliert. Kongress Deutsche Gesellschaft für Chirurgie, 26 – 29.03.2019, ICM München.
Preis: „Best Poster“ für das Poster „Diabetes mellitus Typ 2 und Fettleibigkeit werden mutmaßlich durch den mTOR Signalweg unter der Kontrolle der miRNA-496 reguliert.“
Feiner LK, Thomas A, Rubie C, Glanemann M. Evaluierung des Expressionsprofils altersassoziierter Plasmaproteine. 136. Kongress Deutsche Gesellschaft für Chirurgie, 26 – 29.03.2019, ICM München.
Thomas A, Rubie C und Glanemann M. Evaluierung des Expressionsprofils altersassoziierter Plasmaproteine. Gerontologie und Geriatrie Kongress 2018, Köln, 06.- 08.09.2018.
Rubie C und Glanemann M. A new regulatory mechanism involved in ageing. International Conference on Aging and Disease, Nizza, Frankreich, 05. - 08.10.2018.
C. Rubie, J. Zimmer und M. Glanemann. Diabetes mellitus type 2 and obesity are potentially regulated by the mTOR pathway under the control of miR-496. International Conference on Aging and Disease, Nizza, Frankreich, 05. - 08.10.2018.
C. Rubie. 17. Konferenz der German Society of Preventive and Anti-Aging Medicine, GSAAM e.V. Die molekularen Grundlagen des Alterns. München, 4. – 6. 05. 2017. Expression and regulation of mTOR, a key modulator of ageing and age-related disease.
Rubie C. 2nd Molecular Biology of Ageing Meeting 2017. Groningen, Holland, 8.-11-10.2017. Expression and regulation of mTOR, a key modulator of ageing and age-related disease.
Kolokotronis T, Avramis D, Rubie C, Glanemann. 12th International Congress of the European-African Hepato-Pancreato-Biliary Association (12th Biennal E-AHPBA), Mainz, 23. - 26.05.2017. Expression and regulation of mTOR, a key modulator of ageing and age-related disease, in pancreatic carcinoma.
Kolokotronis T, Avramis D, Rubie C, Glanemann. DGCH ICM München, 21. – 24.03. 2017. Expression and regulation of mTOR, a key modulator of ageing and age-related disease, in pancreatic carcinoma.
Kolokotronis T, Rubie C, Halajda B, Glanemann M. Functional interaction of microRNAs with chemokine ligands and their expression in the microenvironment of colorectal tumors. Kolokotronis T, Rubie C, Halajda B, Glanemann M. Viszeralmedizin Dresden - 13.-16.09.2017.
Kolokotronis T, Rubie C, Halajda B, Glanemann M. CXCL12/CXCR4 display an inverse mRNA expression profile in gastric carcinoma which correlates with tumor progression. Viszeralmedizin Dresden - 13.-16.09.2017.
Kolokotronis T, Rubie C, Halajda B, Glanemann M. Chemokine receptor CCR6 expression is regulated by miR-518a-5p in colorectal cancer cells. Viszeralmedizin Dresden - 13.-16.09.2017.
Kolokotronis T, Rubie C, Halajda B, Glanemann M.Expression and regulation of mTOR, a key modulator of ageing and age-related disease, in pancreatic carcinoma. Viszeralmedizin Dresden - 13.-16.09.2017.
Kolokotronis T, Rubie C, Halajda B, Glanemann M.Chemokine receptor CCR6 expression is regulated by miR-518a-5p in colorectal cancer cells. Chirurgische Forschungstage Köln- 21. – 23.09.2017.
Kolokotronis T, Rubie C, Halajda B, Glanemann M. Expression and regulation of mTOR, a key modulator of ageing and age-related disease, in pancreatic carcinoma. Chirurgische Forschungstage Köln- 21. – 23.09.2017.
Kölsch K, Rubie C, Glanemann M. Einfluss der präoperativen FOLFOX Chemotherapie auf die CCL20/CCR6 Expression in kolorektalen Lebermetastasen. 133. Kongress der Deutschen Gesellschaft für Chirurgie, 26.04. – 29.04.2016, ICM Berlin.
Rubie C, Glanemann M. Chemokine receptor CCR6 expression is regulated by miR-518a-5p in colorectal cancer cells. 132. Kongress der Deutschen Gesellschaft für Chirurgie, 28.04. – 01.05.2015, ICM München.
Rubie C, Oliveira Frick V, Glanemann M. Functional interaction of microRNAs with chemokine ligands and their expression in the microenvironment of colorectal tumors. 131. Kongress der Deutschen Gesellschaft für Chirurgie, Berlin 25.-28.03.2014.
Rubie C, Oliveira Frick V, Kölsch K, Glanemann M. MiR-21 functionally interacts with the 3´UTR of chemokine CCL20 and downregulates CCL20 expression in miR-21 transfected colorectal cancer cells. 17. Chirurgische Forschungstage, Frankfurt 2013.
Rubie C, Oliveira Frick V, Kölsch K, Glanemann M. CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells. 17. Chirurgische Forschungstage, Frankfurt 2013.
Oliveira Frick V, Rubie C, Kölsch K, Glanemann M. CCR6/CCL20-Chemokinexpressionsprofil bei Patienten mit malignen kolorektalen Erkrankungen. 17. Chirurgische Forschungstage, Frankfurt 2013.
Oliveira Frick V, Rubie C, Kölsch K, Glanemann M. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases. 17. Chirurgische Forschungstage, Frankfurt 2013.
Oliveira Frick V, Rubie C, Kölsch K, Glanemann M. Thoracotomy procedures effect cytokine levels after thoracoabdominal esophagectomy. 17. Chirurgische Forschungstage, Frankfurt 2013.
Kölsch K, Oliveira Frick V, Rubie C, Glanemann M. MiR-21 and its target gene CCL20 are both highly over-expressed in the microenvironment of CRC tumors: consequences for their regulation. 17. Chirurgische Forschungstage, Frankfurt 2013.
Kölsch K, Oliveira Frick V, Rubie C, Glanemann M. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies. 17. Chirurgische Forschungstage, Frankfurt 2013.
Rubie C, Frick V, Faust S, Vicinus B, Schilling MK. CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells. 128. Kongress der Deutschen Gesellschaft für Chirurgie, 03.-05. Mai 2011, München, Langenbecks Archives of Surgery 2011;396:551-583.
Frick V, Rubie C, Wagner M, Schilling MK. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies. 128. Kongress der Deutschen Gesellschaft für Chirurgie, 03.-05. Mai 2011, München, Langenbecks Archives of Surgery 2011;396:551-583.
Frick V, Rubie C, Wagner M, Schilling MK. Cytogenetic effects of immunosuppressive drugs in vitro and in vivo. 128. Kongress der Deutschen Gesellschaft für Chirurgie, 03.-05. Mai 2011, München, Langenbecks Archives of Surgery 2011;396:551-583.
Rubie C, Oliveira Frick V, Wagner M, Schilling MK. Chemokine und Organtropismus. Jahrestagung der Deutschen Gesellschaft für Hämatologie und Onkologie e. V. (DGHO), 01.-05. Oktober 2010, Berlin.
Oliveira Frick V, Rubie C, Wagner M, Schilling MK. Changes in CXC-chemokine Expression during early onset of colorectal malignancies. 4th Mildred Scheel Cancer Conference, 19.-21. May 2010, Königswinter.
Oliveira Frick V, Rubie C, Wagner M, Schilling MK. IL-8 expression correlates with induction, progression and metastatic potential of colorectal cancer. 4th Mildred Scheel Cancer Conference, 19.-21. May 2010, Königswinter.
Oliveira Frick V, Rubie C, Wagner M, Schilling MK. CXC-chemokines in patients with malignant pancreatic diseases. 4th Mildred Scheel Cancer Conference, 19.-21. May 2010, Königswinter.
Rubie C, Oliveira Frick V, Wagner M, Schilling MK. CCR6 involvement in metastasis of the liver. 126.Kongress der Deutschen Gesellschaft für Chirurgie, 28.04.-01.05. 2009, München.
Oliveira Frick V, Rubie C, Wagner M, Schilling MK. Enhanced CXC-chemokine expression in patients with malignant pancreatic diseases. 126. Kongress der Deutschen Gesellschaft für Chirurgie, 28.04.-01.05. 2009, München.
Oliveira Frick V, Rubie C, Wagner M, Schilling MK. Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures. Chirurgische Forschungstage, 25.-27. September 2008, Freiburg, Langenbecks Archives of Surgery 2008;393:759-815.
Rubie C, Oliveira Frick V, Wagner M, Schilling MK. IL-8 expression correlates with induction, progression and metastatic potential of colorectal cancer. Chirurgische Forschungstage, 25.-27. September 2008, Freiburg, Langenbecks Archives of Surgery 2008;393:759-815.
Rubie C, Oliveira Frick V, Wagner M, Schilling MK. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Chirurgische Forschungstage, 25.-27. September 2008, Freiburg, Langenbecks Archives of Surgery 2008;393:759-815.
Oliveira Frick V, Rubie C, Wagner M, Schilling MK. Potential biomarkers for colorectal liver metastasis. Chirurgische Forschungstage, 25.-27. September 2008, Freiburg, Langenbecks Archives of Surgery 2008;393:759-815.
Oliveira Frick V, Rubie C, Wagner M, Schilling MK. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Berlin Conference on Invasion and Metastasis, MDC 26.-29. März 2008, Berlin.
Oliveira Frick V, Rubie C, Wagner M, Schilling MK. IL-8 expression correlates with induction, progression and metastatic potential of colorectal cancer. Berlin Conference on Invasion and Metastasis, MDC 26.-29. März 2008, Berlin.
Oliveira Frick V, Rubie C, Wagner M, Schilling MK. CXC chemokines in patients with malignant pancreatic diseases. Berlin Conference on Invasion and Metastasis, MDC 26.-29. März 2008, Berlin.
Rubie C, Oliveira Frick V, Wagner M, Schilling MK. ENA-78 expression correlates with early stage onset of colorectal carcinoma. 11. Chirurgische Forschungstage, 15.-17. November 2007, Saarbrücken, Langenbecks Archives of Surgery
2007;392:769-838.
Rubie C, Oliveira Frick V, Wagner M, Schilling MK. Differential CXC receptor expression in colorectal cancer. 11. Chirurgische Forschungstage, 15.-17. November 2007, Saarbrücken, Langenbecks Archives of Surgery 2007;392:769-838.
Oliveira Frick V, Rubie C, Wagner M, Schilling MK. CXC-chemokines in patients with malignant pancreatic diseases. Chirurgische Forschungstage, 15.-17. November 2007, Saarbrücken Langenbecks Archives of Surgery 2007;392:769-838.
Rubie C, Kempf K, N, Oliveira V, Tilton B, Rau B, Schilling MK. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. 123. Kongress der Deutschen Gesellschaft für Chirurgie 02.-05. Mai 2006, Berlin.
Rubie C, Oliveira V, Kempf K, Ludwig B Tilton B, Rau B, Schilling MK. Chemokine receptor CCR6 in colorectal cancer metastasis. 4. Biebrich Interdisciplinery Conference (BIC) 29. September 2005, Wiesbaden – Biebrich.
Rubie C, Kempf K, Oliveira Frick V, Forster N, Ludwig B, Tilton B, Schilling M. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. ELS0-European Life Scientist Organization- Meeting combining the 9th International
World Congress of Cell Biology, 03.-06. September 2005, Dresden.
Oliveira Frick V, Kempf K, Forster N, Ludwig B Tilton B, Rau B, Schilling MK, Rubie C,. Detection of MIP3alpha and its receptor CCR6 in human colorectal cancer and colorectal liver metastases. ELS0- European Life Scientist Organization-
Meeting combining the 9th International World Congress of Cell Biology, 03.-06. September 2005, Dresden.
Krüger CM, Behrendt D, Glaser E, Herboth E, Rubie C, Schilling MK, Rau BM. Targeted disruption of monocyte chemoattractant protein-1 (MCP-1) or receptor CCR2b in experimentale acue pancreatitis: influence on local and systemic disease severity. 37th European Pancreatic Club (EPC) Meeting 06.-08. Juli 2005, Graz, Österreich.
Rubie C, Hans J, Su, T, Tilton B, Kempf, K, Brittner, B, Ludwig B, Schilling M. (2004). Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. ELS0 - European Life
Scientist Organization - Meeting combining the 8th International World Congress of Cell Biology, 04.-08. September 2004, Nizza/Frankreich.
